Mapping the Patient Journey Towards Actionable Beyond the Pill Solutions for NCDs

Press and media
Noncommunicable diseases (NCDs) are responsible for 71% of all worldwide mortality each year. Despite a wealth of knowledge that offers evidence-based expert guidance for managing illness and preventing risk, in many parts of the world whether in high-income or low-income countries, we are still...

IAPO joins the #TeamVaccines campaign

Press and media
IAPO is proud to be part of the #TeamVaccines, a global digital campaign designed to build confidence in COVID-19 vaccines launched by the International Federation of Pharmaceutical Manufacturers & associations (IFPMA). We support this campaign because we believe vaccination is not just an...

Call to Heads of State of the African Union to Ratify the African Medicines Agency Treaty

Press and media
Endorse and sign the call Patients, Civil Society and Youth Organisations, Products Development Partnerships, Health and Pharmaceutical Industries, and all stakeholders who are striving to improve global public health - welcome the African Medicines Agency (AMA) Treaty made at the 32nd ordinary...

Building the IAPO membership community in 2021

Members
2020 was a turning point for us at IAPO, where the COVID-19 pandemic and all its lessons gave us an opportunity to review, adapt and improve our work, and more importantly strengthen the IAPO membership community. We worked hard last year to amplify the patients’ voice at various fronts -...

IAPO statements at the WHO Executive Board 148th session, January 2021

Press and media
The 148th session of the World Health Organization’s Executive Board (EB) took place on 18-26 January 2021 in Geneva, Switzerland with a focus on the challenges of COVID-19, the need to strengthen health systems. The Governing Board Chair, and Governing Board Secretary were able to attend a...

WHO Executive Board recommends the Global Patient Safety Action Plan 2021-2030 to 74th World Health Assembly

Press and media
We at IAPO are extremely delighted that on Thursday 21st January 2020, the World Health Organization (WHO) Member States and non-state actors expressed their unanimous support to the proposed Global Patient Safety Action Plan 2021-2030 as a key instrument to guide patient safety improvements at all...

Share your patient safety story – help reach ZERO HARM!

Press and media
The International Alliance of Patients’ Organisations (IAPO) collaborated with BD–Europe to amplify the voices of patients who have been afflicted with healthcare-associated infections (HAIs), sepsis, antimicrobial resistance (AMR) or medication errors. As part of this Voices of Safety...

IAPO's COVID-19 Response Activity Grant Scheme

Members
In 2020, IAPO launched the COVID-19 Response Activity Grant Scheme to support IAPO members working on the frontline to support patients during the pandemic. Through a competitive 2-stage selection process initiated via the 9 th Global Patients Congress (GPC 2020) Open Call, we invited our Member...

Patient Care After COVID: Providers Must Correct ‘One Size Fits All’ Approach

Press and media
The 2nd Asia Pacific Patients Congress was held as IAPO’s second fully digital congress on 3-4 December 2020 with over 3000 registered from 66 countries with 298 patient groups, who attended 20 sessions with 66 speakers from 16 countries. Patient groups and thousands of attendees drew...

Can we do more to prevent antimicrobial resistance?

Press and media
Antimicrobial resistance (AMR) is a natural process of pathogens’ adaptation to the drugs we use to kill them, which should normally have a slow evolution-like pace. Our inappropriate use of common antibiotics, antiviral agents and other drugs on all fronts of human and animal health...

Pages